OMX Nordic 40
2.412,36
PKT
+56,32
PKT
+2,39
%
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 18.02.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 18.02.20 | AstraZeneca overweight | Barclays Capital | |
| 18.02.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 18.02.20 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 12.02.20 | Nokia buy | UBS AG | |
| 12.02.20 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 11.02.20 | Novo Nordisk Hold | Deutsche Bank AG | |
| 10.02.20 | Nokia Equal weight | Barclays Capital | |
| 10.02.20 | ABB (Asea Brown Boveri) buy | Kepler Cheuvreux | |
| 10.02.20 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 07.02.20 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 07.02.20 | Nokia buy | UBS AG | |
| 07.02.20 | Nokia Neutral | Credit Suisse Group | |
| 07.02.20 | Nokia Neutral | JP Morgan Chase & Co. | |
| 07.02.20 | Volvo (B) Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.02.20 | Nokia Sell | Goldman Sachs Group Inc. | |
| 06.02.20 | Nokia Equal weight | Barclays Capital | |
| 06.02.20 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 06.02.20 | Novo Nordisk Outperform | Credit Suisse Group | |
| 06.02.20 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 06.02.20 | Novo Nordisk Neutral | UBS AG | |
| 06.02.20 | Nokia Neutral | Credit Suisse Group | |
| 06.02.20 | Nokia Sell | Goldman Sachs Group Inc. | |
| 06.02.20 | Novo Nordisk overweight | Barclays Capital | |
| 06.02.20 | Nokia Neutral | JP Morgan Chase & Co. | |
| 06.02.20 | Novo Nordisk Outperform | Bernstein Research | |
| 06.02.20 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 06.02.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 06.02.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.02.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 06.02.20 | A.P. Moeller - Maersk A-S (B) Outperform | Credit Suisse Group | |
| 05.02.20 | Novo Nordisk overweight | Barclays Capital | |
| 05.02.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 05.02.20 | Novo Nordisk Outperform | Bernstein Research | |
| 05.02.20 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 05.02.20 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 05.02.20 | Volvo (B) Sell | UBS AG | |
| 05.02.20 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 05.02.20 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 05.02.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. |